Clinical Guidances

PCSS-B Guidance: Acute Pain

PCSS-B Guidance: Management of Psychiatric Medications in Patients Receiving Buprenorphine/Naloxone

PCSS-B Guidance: Monitoring of Liver Function Tests and Hepatitis in Patients Receiving Buprenorphine/Naloxone

PCSS-B Guidance: Opioid Therapies and Drug Interactions

PCSS-B Guidance: Physician Billing for Office-Based Treatment of Opioid Dependence

PCSS-B Guidance: Pregnancy and Buprenorphine Treatment

PCSS-B Guidance: Transfer from Methadone to Buprenorphine

PCSS-B Guidance: Psychosocial Aspects of Treatment in Patients Receiving Buprenorphine/Naloxone

PCSS-B Guidance: Buprenorphine Induction

PCSS-B Adherence Diversion and Misuse of Sublingual Buprenorphine

PCSS-B Guidance: Drug Enforcement Administration Requirements for Prescribers and Dispensers of Buprenorphine and buprenorphine/Naloxone

PCSS-B Guidance: Treatment of Opioid Dependent Adolescents and Young Adults Using Sublingual Buprenorphine

PCSS-B Guidance: The Off-Label Use of Sublingual Buprenorphine and Buprenorphine/Naloxone for Pain


Copyright © 2012 PCSS-B   |  Disclaimer – Any information/materials that is provided/obtained on PCSS-B should not be construed as medical advice.